Quetiapine Efficacy in Bipolar Depression Study

NCT00523601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2008-10-06

No results posted yet for this study

Summary

To reassure the clinical study data on Seroquel antidepressant efficacy in patients who are diagnosed as bipolar depression

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joon-Woo Bahn · AstraZeneca Korea

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-10-31
Completion
2007-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00523601 on ClinicalTrials.gov